Advanced search×

[Pleiotropic effects of thrombomodulin in the management of DIC].

Takashi T Ito and Ikuro I Maruyama

Rinsho Ketsueki 52(6):356-60 (2011) PMID 21737987

Version: za2963e q8zaa q8zbb q8zc2 q8zdb q8ze6 q8zfe q8zg1

Similar articles you may find interesting…

  1. Unintentional discontinuation of statins may increase mortality after traumatic brain injury in elderly patients: a preliminary observation.
    Alessandro Orlando, David Bar-Or, and Patrick J Offner

    J Clin Med Res 5(3):168-73 (2013) PMID 23671542

    The abrupt discontinuation of statin therapy has been suggested as being deleterious to patient outcomes. Although pre-injury statin (PIS) therapy has been shown to have a protective effect in elderly trauma patients, no study has examined how this population is affected by its abrup...
    PDF not found
  2. Trends in the medical management of patients with heart failure.
    Samuel W Joffe, Matthew Dewolf, and Robert J Goldberg

    J Clin Med Res 5(3):194-204 (2013) PMID 23671545

    We reviewed the medical records of 9,748 residents of the Worcester, MA, metropolitan area who were hospitalized with ADHF at all 11 central Massachusetts medical centers in 1995, 2000, 2002, and 2004. Between 1995 and 2004, respectively, the prescription upon hospital discharge of b...
    PDF not found
  3. The cost effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK.
    Anthony J Batty, Ryan N Hansen, and Sean D Sullivan

    J Med Econ (2013) PMID 23647483

    At 2 years, treatment with onabotulinumtoxinA was associated with an increase in costs of £1,367 and an increase in QALYs of 0.1 compared to placebo, resulting in an incremental cost-effectiveness ratio (ICER) of £15,028. Treatment with onabotulinumtoxinA reduced headache days by an estimated 38 d...